KASEY BAMEL: Open Payments
NPI 1487106886 · LA JOLLA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,735 in 10 payments from 7 companies in 2025. Trend: 2023 $1,131 · 2024 $5,557 · 2025 $1,735
Consulting: $757Food & beverage: $591Speaker / faculty: $234Speaker / faculty: $154
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 3 | $991 |
| JAZZ PHARMACEUTICALS INC. | 2 | $159 |
| AstraZeneca Pharmaceuticals LP | 1 | $154 |
| Syndax Pharmaceuticals, Inc. | 1 | $121 |
| E.R. Squibb & Sons, L.L.C. | 1 | $119 |
| SpringWorks Therapeutics, Inc. | 1 | $115 |
| Astellas Pharma US Inc | 1 | $78 |
Products named: LIBTAYO, ZIIHERA, REVUFORJ, OPDIVO, Vyloy.
Industry payments across CA — which companies pay providers there.
